Phase 4 T2DM Clinical Trials
8 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–8 of 8 trials
Recruiting
Phase 4
Effect of Early Combination Antihyperglycemic Treatment on Metabolic Control in Individuals With Type 2 Diabetes
Type 2 Diabetes Mellitus (T2DM)
University Medical Centre Ljubljana90 enrolled1 locationNCT06613854
Recruiting
Phase 4
The Impact of Semaglutide Compared to Energy Restriction on Type 2 Diabetes
Type 2 Diabetes Mellitus (T2DM)SemaglutideCaloric Restriction
Second Affiliated Hospital of Nanchang University100 enrolled1 locationNCT07272343
Recruiting
Phase 4
Glycemic Variability of Combination Therapies in T2DM
Type 2 Diabetes Mellitus (T2DM)
JW Pharmaceutical178 enrolled1 locationNCT07442006
Recruiting
Phase 4
GLP1-RAs Effects on Inflammatory and Endothelial Biomarkers in T2DM
T2DM (Type 2 Diabetes Mellitus)
Federico II University80 enrolled2 locationsNCT07314684
Recruiting
Phase 4
Efficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor Glycemic Control
T2DM (Type 2 Diabetes Mellitus)
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.430 enrolled1 locationNCT07244003
Recruiting
Phase 4
Effect of Treatment With Finerenone on Cardio-Renal Target Organ Damage in Patients With Type 2 Diabetes.
Cardiovascular DiseasesType 2 Diabetes Mellitus (T2DM)Chronic Kidney Disease Due to Type 2 Diabetes Mellitus
University of Aarhus80 enrolled1 locationNCT07026539
Recruiting
Phase 4
Cofrogliptin Once Every 2 Weeks as Add-on Therapy to Metformin and Dapagliflozin Versus Daily Linagliptin in Patients With Type 2 Diabetes.
T2DM
Huazhong University of Science and Technology170 enrolled2 locationsNCT07019012
Completed
Phase 4
Relationship of serological levels for death receptors (TNFR1, TRAIL -R2, FAS ) With early pancreatic ß cell Apoptosis and Follow up after DPP4 inhibitors treatment in Syrian type 2 diabetic and impaired fasting glucose patients
the research problem is to study serum apoptotic biomarkers and inflammatory mediators in naive drug prediabetes to determine whether drug intervention (DPP4inhibitors ) can slow down or reverse apoptosis of pancreatic beta cell in order to limit conversion prediabetes to T2DM .
rama ayash -Damascus university ,-pharmacy college88 enrolled1 locationACTRN12624001135505